| CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. EJ Schattner, KB Elkon, DH Yoo, J Tumang, PH Krammer, MK Crow, ... The Journal of experimental medicine 182 (5), 1557-1565, 1995 | 338 | 1995 |
| Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU. 1 F Rosenbauer, BM Owens, L Yu, JR Tumang, U Steidl, JL Kutok, ... Nature genetics 38 (1), 27-37, 2006 | 265 | 2006 |
| PD‐L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding X Zhong, JR Tumang, W Gao, C Bai, TL Rothstein European journal of immunology 37 (9), 2405-2410, 2007 | 256 | 2007 |
| c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function HC Liou, Z Jin, J Tumang, S Andjelic, KA Smith, ML Liou International immunology 11 (3), 361-371, 1999 | 223 | 1999 |
| A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. SM Friedman, DN Posnett, JR Tumang, BC Cole, MK Crow Arthritis and rheumatism 34 (4), 468-480, 1991 | 177 | 1991 |
| Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia RJ Greenwald, JR Tumang, A Sinha, N Currier, RD Cardiff, TL Rothstein, ... Blood 103 (4), 1475-1484, 2004 | 171 | 2004 |
| c‐Rel is essential for B lymphocyte survival and cell cycle progression JR Tumang, A Owyang, S Andjelic, Z Jin, RR Hardy, ML Liou, HC Liou European journal of immunology 28 (12), 4299-4312, 1998 | 164 | 1998 |
| Peritoneal and splenic B‐1 cells are separable by phenotypic, functional, and transcriptomic characteristics JR Tumang, WD Hastings, C Bai, TL Rothstein European journal of immunology 34 (8), 2158-2167, 2004 | 132 | 2004 |
| Cutting edge: spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors JR Tumang, R Francés, SG Yeo, TL Rothstein The Journal of Immunology 174 (6), 3173-3177, 2005 | 127 | 2005 |
| Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and … S Crosignani, P Bingham, P Bottemanne, H Cannelle, S Cauwenberghs, ... Journal of medicinal chemistry 60 (23), 9617-9629, 2017 | 126 | 2017 |
| c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis AM Owyang, JR Tumang, BR Schram, CY Hsia, TW Behrens, ... The Journal of Immunology 167 (9), 4948-4956, 2001 | 88 | 2001 |
| Peritoneal B‐2 cells comprise a distinct B‐2 cell population with B‐1b‐like characteristics WD Hastings, JR Tumang, TW Behrens, TL Rothstein European journal of immunology 36 (5), 1114-1123, 2006 | 83 | 2006 |
| Immunoglobulin secretion by B1 cells: differential intensity and IRF4‐dependence of spontaneous IgM secretion by peritoneal and splenic B1 cells NE Holodick, JR Tumang, TL Rothstein European journal of immunology 40 (11), 3007-3016, 2010 | 78 | 2010 |
| Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell … SM Friedman, MK Crow, JR Tumang, M Tumang, YQ Xu, AS Hodtsev, ... The Journal of experimental medicine 174 (4), 891-900, 1991 | 77 | 1991 |
| A novel subpopulation of B‐1 cells is enriched with autoreactivity in normal and lupus‐prone mice X Zhong, S Lau, C Bai, N Degauque, NE Holodick, SJ Steven, J Tumang, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 76 | 2009 |
| Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. JR Tumang, DN Posnett, BC Cole, MK Crow, SM Friedman The Journal of experimental medicine 171 (6), 2153-2158, 1990 | 74 | 1990 |
| Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9 L Busconi, JW Bauer, JR Tumang, A Laws, K Perkins-Mesires, AS Tabor, ... The Journal of Immunology 179 (11), 7397-7405, 2007 | 70 | 2007 |
| Characterization of the selective indoleamine 2, 3-dioxygenase-1 (IDO1) catalytic inhibitor EOS200271/PF-06840003 supports IDO1 as a critical resistance mechanism to PD-(L) 1 … B Gomes, G Driessens, D Bartlett, D Cai, S Cauwenberghs, S Crosignani, ... Molecular cancer therapeutics 17 (12), 2530-2542, 2018 | 69 | 2018 |
| CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. Y Li, GR Sun, JR Tumang, MK Crow, SM Friedman The Journal of clinical investigation 94 (6), 2525-2531, 1994 | 65 | 1994 |
| Increased frequency of Vβ17‐positive T cells in patients with rheumatoid arthritis G Zagon, JR Tumang, Y Li, SM Friedman, MK Crow Arthritis & Rheumatism: Official Journal of the American College of …, 1994 | 62 | 1994 |
